Korro Bio Inc

Research Korro Bio Inc (KRRO) on Bullrun: market cap USD 190.31M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerKRRO
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 190.31M
• Financial periodFY2025
• RevenueUSD 6.39M
• Revenue growth181.5%
• Net income-USD 117.26M
• Free cash flow-USD 79.08M

Valuation Snapshot

latest market cap is USD 190.31M.

About Korro Bio Inc

Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States. The company's lead product candidate is KRRO-121 for the treatment for hyperammonemia. It uses its RNA editing platform, Oligonucleotide Promoted Editing of RNA to generate differentiated RNA editing product candidates.

Frequently asked questions

What is Korro Bio Inc's market cap?

Korro Bio Inc's market capitalization is USD 190.31M.

What does Korro Bio Inc do?

Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States.